| EPB087 | Where do we stand in the path towards cervical cancer elimination in Mozambique? | E-poster | Malignancies (AIDS and non-AIDS) |
| EPB088 | The role of expanded human papillomavirus genotyping in detecting high-grade cervical dysplasia by HIV status in Botswana | E-poster | Malignancies (AIDS and non-AIDS) |
| EPB089 | Persistent low-level viremia may increase the risk of cancer in people living with HIV | E-poster | Malignancies (AIDS and non-AIDS) |
| EPB090 | Kaposi sarcoma in ART-treated PLWH and HIV-uninfected people: differences in viral and immune characteristics | E-poster | Malignancies (AIDS and non-AIDS) |
| EPB091 | Evaluation of screening algorithms based on HPV testing with partial genotyping for the prevention of cervical cancer among HIV-infected women in resource-limited countries: results of the ANRS 12375 study | E-poster | Malignancies (AIDS and non-AIDS) |
| PEMOB34 | Prevalence and risk factors for anal dysplasia among men who have sex with men living with HIV: the HPV Screening and Vaccine Evaluation (HPV-SAVE) Study | Poster exhibition | Malignancies (AIDS and non-AIDS) |
| EPC321 | Retention of clients on daily oral HIV pre-exposure prophylaxis in Vietnam | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPC322 | Acceptability of an mHealth intervention to promote the use of pre-exposure prophylaxis among individuals at increased risk of HIV. The case of the Jichunge smartphone app in Dar es Salaam, Tanzania | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPC323 | 'I was scared dating… who would take me with my status?' Living with HIV in the UTT era in Johannesburg, South Africa | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| EPC324 | Geographic disparities in HIV PrEP pharmacy reversals, a novel observational data indicator of PrEP non-adherence | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |